字号·· | 护眼
semafor

FDA长期空缺FDA's long-term vacancy

点「原文对照」整页切到原文,或双击某段只看那段的原文。

安德鲁·凯利/资料照片/路透社Andrew Kelly/File Photo/Reuters

美国食品药品监督管理局(FDA)的领导层真空短期内难以填补。

The leadership vacuum at the FDA won’t be filled anytime soon.

白宫在最后一刻决定撤回对海蒂·奥弗顿的提名,这使得国会在跛脚鸭会期采取行动的可能性几乎为零。参议院卫生委员会主席、路易斯安那州共和党参议员比尔·卡西迪预测,这一职位将“落到参议院民主党人手中”。白宫想要找到一位既支持总统唐纳德·特朗普的卫生议程、又能赢得新一届参议院多数党支持的提名人选,希望渺茫。

The White House’s last-minute decision to pull the nomination of Heidi Overton leaves the chances of Congress acting during the lame duck around zero, with the Senate health committee’s chair Bill Cassidy, R-La., predicting the job will “fall to the Senate Democrats.”The White House has a slim chance of finding a nominee who supports President Donald Trump’s health agenda and who could win support from the new Senate majority.

多位前FDA官员告诉我,他们预计未来两年将由一连串代理局长填补这一职位。潜在的临时领导人之一是萨拉·布伦纳,她曾在2025年初担任代理局长,后于今年早些时候离开该机构,前往美国卫生与公众服务部担任公共卫生高级顾问。另一个被提及的人选是卡里姆·米哈伊尔,他是FDA负责疫苗和生物制品的最高监管官员。

Former FDA officials told me they expect a string of acting commissioners to fill in for the next two years. One potential temporary leader is Sara Brenner, who held the acting title in early 2025 before departing the agency earlier this year to work as a senior counselor for public health at HHS. Another name being floated is Karim Mikhail, the FDA’s top regulator of vaccines and biologics.

领导层空缺出现之际,国会正着手处理行业用户费问题,这是FDA约一半资金的关键来源。用户费授权每五年需要重新批准一次。

The leadership void arrives as Congress takes up industry user fees, a critical source of about half of FDA’s funding. They require approval every five years.

议员们可能会在该一揽子方案中附加机构改革内容。FDA领导人已敦促国会赋予监管机构新的权力,以强制召回药品并迫使制药商共享其供应链数据。在没有常任局长的情况下,目前不清楚谁会推动这些改革。

Lawmakers could attach agency reforms to the package. FDA leaders have urged Congress to empower regulators with new authorities to mandate drug recalls and compel drugmakers to share data on their supply chains. Without a permanent agency leader, it’s unclear who would champion these changes.

而且,两党都有人对用户费资助结构本身持批评态度。将于明年领导参议院卫生委员会的佛蒙特州独立参议员伯尼·桑德斯告诉记者,他与卫生与公众服务部部长小罗伯特·F·肯尼迪一样担心,用户费项目构成了“令人难以置信的利益冲突”。桑德斯周三对记者说:“如果我们要监管一个非常、非常庞大的行业,那么不让这个行业为自己的监管买单,或许是个好主意。”

And there are critics of the funding structure itself on both sides of the aisle. Sen. Bernie Sanders, I-Vt., who will lead the Senate’s health committee next year, told reporters he shares concerns with HHS Secretary Robert F. Kennedy Jr. that the user-fee programs pose an “incredible conflict of interest.”“If we’re going to regulate a very, very significant industry, it might be a good idea not to have the industry paying for their regulation,” Sanders told reporters on Wednesday.

如果用户费项目不能续期,国会将不得不拿出超过35亿美元的纳税人资金来填补缺口。而且该机构也不会有常任领导人来为此争取。

If the user-fee programs are not renewed, Congress would have to come up with more than $3.5 billion in taxpayer money to cover the gap. And the agency won’t have a permanent leader to make the argument for it.

我和同事本周报道,共和党人正在考虑让堪萨斯州共和党参议员罗杰·马歇尔接替奥弗顿。马歇尔周三拒绝就是否仍在考虑之列发表评论。

My colleagues and I reported this week that Republicans were looking at Sen. Roger Marshall, R-Kan., as a potential Overton replacement. Marshall declined to comment on Wednesday on whether he was still under consideration.

阅读媒体原文 ↗